Label

How We Work

Grant

Back

Print

University of California San Francisco


October 2008
to engineer naturally occurring erythrotropic bacteria to target malaria infected red blood cells to serve as a potential prophylactic and treatment for malaria in humans.
$100,000
12
Discovery and Translational Sciences
Global Health
San Francisco, California
http://www.ucsf.edu

Visit Our Blog